Inhibition of nucleotide excision repair and sensitisation of cells to DNA cross-linking anticancer drugs by F 11782, a novel fluorinated epipodophylloid-Reference-Cited by-同舟云学术

Inhibition of nucleotide excision repair and sensitisation of cells to DNA cross-linking anticancer drugs by F 11782, a novel fluorinated epipodophylloid

Published:2002-01 Issue:2 Volume:63 Page:251-258
ISSN:0006-2952
Container-title:Biochemical Pharmacology
language:en
Short-container-title:Biochemical Pharmacology

Author:

Barret Jean-Marc,Cadou Mathilde,Hill Bridget T

Publisher

Elsevier BV

Subject

Pharmacology,Biochemistry

Reference39 articles.

1. Drug resistance: an overview of the current state of the art;Hill;Int. J. Oncol.,1996

2. Increased nucleotide excision repair in cisplatin-resistant ovarian cancer cells. Role of ERCC1-XPF;Ferry;Biochem. Pharmacol.,2000

3. DNA repair mechanisms associated with cellular resistance to antitumor drugs: potential novel targets;Barret;Anti-Cancer Drugs,1998

4. DNA excision repair;Sancar;Annu. Rev. Biochem.,1996

5. DNA damage recognition during nucleotide excision repair in mammalian cells;Wood;Biochimie,1999

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting the DNA Damage Response for Cancer Therapy;International Journal of Molecular Sciences;2023-11-02

2. DNA Repair Enzymes Promising in Cancer Therapy; Poly (ADP-Ribose) Polymerase Inhibitors;Gazi Medical Journal;2022-07-01

3. Recent Advances in Therapeutic Application of DNA Damage Response Inhibitors against Cancer;Anti-Cancer Agents in Medicinal Chemistry;2022-02

4. XPA: DNA Repair Protein of Significant Clinical Importance;International Journal of Molecular Sciences;2020-03-22

5. Dual Inhibitors as a New Challenge for Cancer Multidrug Resistance Treatment;Current Medicinal Chemistry;2019-12-02